Surveillance for hepatocellular carcinoma: It is time to move forward
- PMID: 36064304
- PMCID: PMC9597219
- DOI: 10.3350/cmh.2022.0257
Surveillance for hepatocellular carcinoma: It is time to move forward
Keywords: Cancer screening; Hepatocellular carcinoma; Surveillance; Survival.
Conflict of interest statement
The authors have no conflicts to disclose.
Comment in
-
Correspondence on Editorial regarding "Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease".Clin Mol Hepatol. 2023 Jan;29(1):182-184. doi: 10.3350/cmh.2022.0411. Epub 2022 Nov 22. Clin Mol Hepatol. 2023. PMID: 36417888 Free PMC article. No abstract available.
Comment on
-
Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease.Clin Mol Hepatol. 2022 Oct;28(4):851-863. doi: 10.3350/cmh.2022.0037. Epub 2022 Jun 3. Clin Mol Hepatol. 2022. PMID: 36263667 Free PMC article.
References
-
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–249. - PubMed
-
- European Association for the Study of the Liver EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69:182–236. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical